Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population.
Latorre G, Pizarro M, Ford JS, Gándara V, Muñoz G, Araya JC, Bellolio E, Villaseca M, Fuentes-López E, Cortés P, Rollán A, Bufadel ME, Araya R, Vargas JI, Espino A, Sharp A, Agüero C, Donoso A, Bresky G, Pedrero P, Rueda C, Calvo A, Odagaki T, Moriyama T, Ishida T, Parra-Blanco A, Camargo MC, González R, Corvalán AH, Riquelme A; ACHED operative group.
Latorre G, et al. Among authors: gonzalez r.
Gastroenterol Hepatol. 2023 Jun-Jul;46(6):411-418. doi: 10.1016/j.gastrohep.2022.04.004. Epub 2022 May 14.
Gastroenterol Hepatol. 2023.
PMID: 35580739
English, Spanish.